
A new treatment for an advanced form of blood cancer has been recommended for routine NHS use.
It is estimated that about 800 people with Hodgkin lymphoma – which develops in the lymphatic system, a network of vessels and glands throughout the body – could benefit from the decision by the National Institute for Health and Care Excellence (Nice).